Expert insight from our panelists: Morgan Lee, PhD, MPH, CPH Vice President, Research & Marketing Scott Halperin, PharmD Vice President, Employer Pharmacy Benefit Consulting Steve Altenburger, PharmD Senior Pharmacy Benefit Consultant
Patients often describe the emotional fatigue of weighing therapeutic benefits against symptoms that interfere with daily life, and that tradeoff is precisely why clinicians monitor new or worsening reflux closely
The average family premiums for covered workers at firms with 10 to 199 workers and at larger firms have grown at similar rates since 2015 (53% at firms with 10 to 199 workers and 52% at larger firms)
For research designs examining the intersection of metabolic and inflammatory biology, KPV provides a small-peptide anti-inflammatory research tool that operates through fundamentally different mechanisms than the incretin family compounds
Age, gender, tumor burden, variceal bleeding, ascites, and MELD-Na were similar between the two groups
Treatment can be started as a single dose with the most important hyperglycemic excursion (basal-plus) or directly in several doses (basal-bolus)